Arcutis Biotherapeutics Inc (ARQT)
14.99
+0.02
(+0.13%)
USD |
NASDAQ |
Dec 24, 16:00
Arcutis Biotherapeutics Cash from Investing (Quarterly): 84.78M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | -18.04M |
| Biogen Inc | -1.181B |
| Vertex Pharmaceuticals Inc | -348.00M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -34.69M |
| Cash from Financing (Quarterly) | 0.394M |
| Free Cash Flow | -167.80M |
| Free Cash Flow Per Share (Quarterly) | -0.2802 |
| Free Cash Flow to Equity (Quarterly) | -35.63M |
| Free Cash Flow to Firm (Quarterly) | -28.18M |
| Free Cash Flow Yield | -9.83% |